Document:

Exhibit 10.1

 

PURCHASE AND SALE AGREEMENT

 

This Purchase and Sale Agreement (the “Agreement”) is made and entered into by and between Verde Bio Holdings, Inc. with an address of 5 Cowboys Way, Suite 300, Frisco, Texas 75034 (hereinafter referred to as “Buyer”), and ______________________ with an address of _________________________________, (hereinafter referred to as “Seller”).  Buyer and Seller are sometimes referred to below individually as a “Party” or collectively as the “Parties”; and 

 

WHEREAS, Seller owns or has the right to sell the mineral & royalty interests described on Exhibit “A” attached hereto and made a part hereof. 

 

WHEREAS, Buyer desires to purchase from Seller, and Seller desires to sell to Buyer, those certain interests in oil and gas leases that are defined and described as “Properties” hereinbelow, subject to and on the terms and conditions set forth in this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing and the mutual promises, covenants and agreements contained herein and other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, Buyer and Seller agree as follows:

 

Subject to the terms, conditions and provisions of this Agreement, Seller agrees to sell, assign and convey to Buyer  an undivided 100% of Seller’s right, title and interest in and to Seller’s oil, gas and other mineral rights in and to the Properties more specifically described on the attached Exhibit A (“the Properties”) including but not limited to oil royalty, gas royalty, overriding royalty interest, mineral interest and other similar interests which may be produced from said oil, gas and mineral leases and lands1.

 

Terms of this transaction are as follows:

 

1. The purchase price is $430,000.00 in cash, subject to adjustment due to revenue review and title review as mutually agreed upon by Buyer and Seller.

  

2. The closing shall occur on or before April 23, 2021, (the "Closing Date") Prior to the Closing Date Buyer will have the exclusive right to conduct its review of the Properties, including title.  As a condition to the Transaction, Buyer must be fully satisfied, in its sole and absolute discretion, with the results of its due diligence investigation. Buyer’s sole remedy for any alleged breach of this agreement, including but not limited to failure of title to one or more of the Properties, shall be termination of this agreement.  If additional title review is required by the terms of this Agreement, the Closing Date may be extended without amendment by not more than 14 days to accommodate delays attributable to title review. 

 

3. Seller represents that as of the Closing Date, the Properties are free and clear of any and all known liens, mortgages and encumbrances created by Seller. All known mortgages, liens or 

1 The description of the Properties on Exhibit “A” is subject to change pending the Parties verification of title thereto.

encumbrances created by Seller which affect the Properties will either be released or paid-off by Seller on or before the Closing Date. 

 

4.  On the Closing Date, Seller shall execute and deliver to Buyer, and Buyer shall receive, one or more instruments of conveyance.  Such Conveyance of Mineral and Royalty Interest may be hand delivered, or made by Certified U.S. mail or Federal Express (FedEx) to the Buyer.

 

5. Seller shall, upon the reasonable request of the Buyer, execute and deliver all deeds, transfer orders, division orders, letters-in-lieu, curative documents and such other documents as our reasonably necessary to carry out the purposes of this Agreement whether before or after the Closing Date. Seller shall also execute any other conveyance documents as required by Buyer, to the satisfaction of Buyer, or its assigns, in the performance of this Agreement and in order to close on the Properties by the Closing Date.

 

6. Buyer asserts that it is an “accredited investor” within the meaning of Rule 501 under the Securities Act of 1933, as amended. Buyer is financially able to bear the economic risks of acquiring the Properties, including the risk of total investment loss and understands the illiquid nature of this asset class. Buyer is a sophisticated buyer and has such knowledge and experience in the purchase and sale of mineral and royalty interests so as to be capable of evaluating the merits and risks of and making an informed business decision with regard to the acquisition of said purchased interests. 

 

7. The Effective Date of said transaction shall be Production Effective Date of March 1, 2021. Buyer shall be entitled to all revenue from production from the Properties occurring on or after the Effective Date. 

 

8. Buyer reserves the option and right to assign this PSA to another Buyer controlled entity to fulfill the obligations and receive the benefits of this agreement with Seller.

 

9. Prior to the Closing Date or termination of this Agreement, Seller shall not offer the Property for sale to any person or entity, or accept or negotiate any offer to purchase by any person, entity, or other party. 

 

10.  All notices given by Buyer to Seller or by Seller to Buyer, shall be in writing and shall be deemed delivered when actually received, or, if earlier and whether or not actually received, (i) if delivered by courier or in person, when left with any person at the address reflected below, if addressed as set forth below, (ii) if by overnight courier service (such as, by way of example but not limitation, U.S. Express Mail or Federal Express) with instructions for delivery on the next business day, one (1) business day after having been deposited with such courier, addressed as reflected below, and (iii) if delivered by mail, three days after deposited in a Post Office or other depository under the care or custody of the United States Postal Service, enclosed in a wrapper with proper postage affixed (as a certified or registered item, return receipt requested). The addresses of the Parties are the address set out in this Agreement. 

11. This Agreement shall be governed by the laws of the State of Texas, without regard to its conflict of law principles.  All disputes arising from or relating to this Agreement shall be adjudicated in a state district court sitting in Denton County, Texas, and each Party hereby consents to such court's jurisdiction and to such venue.

 

12. This Purchase and Sales Agreement and the rights, duties and obligations represented hereby shall be binding upon the seller hereto, their respective heirs, administrators, executors, representatives, successors and assigns.     

 

ACCEPTED AND AGREED TO, this 19th day of April, 2021

 

 

 

	SELLER

	 

	 

 

	 

	 

	 

	 

	 

	Its: 

	 

	 

 

 

 

	BUYER

	 

	Verde Bio Holdings, Inc.

	 

	 

	 

	 

	 

	 

	 

	By: 

	Scott A. Cox, CEO

	 

Exhibit “A” Lands

 

Exhibit “A” attached to and made part of that certain Purchase and Sale Agreement for purchase of mineral and royalty interests dated April 19, 2021 by and between Verde Bio Holdings, Inc. (“Buyer”) and ______________________ (“Seller”).

 

 

An undivided 100% of all of Seller’s right, title, and interest in the following: 

 

Mineral Interest located in Howard County, Texas

 

 

 

To be further defined by Seller at closing

 

 

It is the intention to convey an undivided 100% interest in the interests described above. This list is not intended to be final and is subject to change. Legal Descriptions and exact interests will be identified in Due Diligence.Exhibit 10.19

 

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT

 

This Second
Amended and Restated Employment Agreement (the “Agreement”) is entered into by and between Keary
Dunn (“Executive”) and Celularity, Inc. (the “Company”), and effective as of, and
contingent upon, the closing of the transactions contemplated by that certain Merger Agreement and Plan of Reorganization dated as of
January 7, 2021, by and among the Company, GX Acquisition Corp., a Delaware corporation, Alpha First Merger Sub, Inc., a Delaware corporation
and a direct, wholly-owned subsidiary of GX, Alpha Second Merger Sub, LLC, a Delaware limited liability company and a direct, wholly-owned
subsidiary of GX (the “Transactions,” and such date, the “Effective Date”).

 

Executive commenced employment
with the Company on March 23, 2020 (the “Start Date”) and is employed by the Company as its General Counsel
& Business Development Head pursuant to an Amended and Restated Employment Agreement with the Company effective January 7, 2021 (the
“Prior Agreement”), which is superseded by this Agreement;

 

Whereas the Prior Agreement
superseded Executive’s employment offer dated February 12, 2020 and the Change in Control Agreement dated February 14, 2020, each
entered into between Executive and the Company;

 

The Company desires to continue
to employ Executive and, in connection therewith, to compensate Executive for Executive’s personal services to the Company from
and after the Effective Date; and

 

Executive wishes to continue
to be employed by the Company and provide personal services to the Company in return for certain compensation.

 

Accordingly, in consideration
of the mutual promises and covenants contained herein, the parties agree to the following:

 

 1. Employment by the Company.

 

1.1 At-Will
Employment. Executive shall continue to be employed by the Company on an “at-will” basis, meaning either the Company
or Executive may terminate Executive’s employment at any time, with or without Cause (as defined in Section 6.2(e) below), Good
Reason (as defined in Section 6.2(d) below), or advance notice. Any contrary representations that may have been made to Executive shall
be superseded by this Agreement. This Agreement shall constitute the full and complete agreement between Executive and the Company on
the “at-will” nature of Executive’s employment with the Company, which may be changed only in an express written agreement
signed by Executive and a duly authorized officer of the Company. Executive’s rights to any compensation following a termination
shall be only as set forth in Section 6 or under any applicable benefit or equity plan.

 

1.2 Position.
Subject to the terms set forth herein, the Company agrees to continue to employ Executive and Executive hereby accepts such continued
employment. In addition, Executive shall continue to serve as General Counsel & Business Development Head. During the term of Executive’s
employment with the Company, and excluding periods of vacation and sick leave to which Executive is entitled, Executive shall devote all
business time and attention to the affairs of the Company necessary to discharge the responsibilities assigned hereunder, and shall use
commercially reasonable efforts to perform faithfully and efficiently such responsibilities.

 

     

    

    

 

1.3 Duties.
Executive will report to the Chief Executive Officer and will render such business and professional services in the performance of Executive’s
duties, consistent with Executive’s position as General Counsel & Business Development Head, as shall reasonably be assigned
to Executive, subject to the oversight and direction of the Chief Executive Officer. Executive shall be expected to continue to
comply with all applicable laws, regulations, rules, directives and other legal requirements of federal, state and other governmental
and regulatory bodies having jurisdiction over the Company and of the professional bodies of which the Company is a member. During Executive’s
employment with the Company, Executive continues to be required to maintain in good standing any licenses and certifications necessary
for the performance of Executive’s duties for the Company. 

 

1.4 Location.
Executive shall perform Executive’s duties under this Agreement principally out of the Company’s corporate headquarters in
Florham Park, New Jersey. In addition, Executive shall make such business trips to such places as may be reasonably necessary or advisable
for the efficient operations of the Company.

 

1.5 Company
Policies and Benefits. The employment relationship between the parties shall continue to be subject to the Company’s written
personnel policies and procedures as they may be adopted, revised, or deleted from time to time in the Company’s sole discretion.
Executive will continue to be eligible to participate on the same basis as similarly-situated employees in the Company’s benefit
plans in effect from time to time during Executive’s employment in accordance with the terms of such benefit plans. Subject to the
preceding sentence, the Company reserves the right to change, alter, or terminate any benefit plan in its sole discretion. All matters
of eligibility for coverage or benefits under any benefit plan shall be determined in accordance with the provisions of such plan. Notwithstanding
the foregoing, in the event that the terms of this Agreement differ from or are in conflict with the Company’s general employment
policies or practices, this Agreement shall control.

 

1.6 Insurance.
While this Agreement is in effect, for actions within the scope of Executive’s employment, the Company will include Executive as
an insured at a level comparable to similarly-situated employees at the Company in its Directors and Officers Liability insurance policy
in effect from time to time.

 

 2. Compensation.

 

2.1 Salary.
Commencing on the Effective Date, Executive shall receive an annualized base salary payable at a rate of $360,000, subject to review and
adjustment from time to time by the Company in its sole discretion, payable subject to standard federal and state payroll withholding
requirements in accordance with the Company’s standard payroll practices (the “Base Salary”).

 

    2

    

    

 

2.2 Bonus.

 

(a) During
Employment. Executive shall be eligible to receive an annual performance bonus (the “Annual Bonus”)
with an annual target of up to 25% (the “Target Percentage”) of Executive’s then-current Base Salary (the
“Target Bonus”). The Annual Bonus will be based upon the assessment of the Board of Directors of the Company
(the “Board”) (or a committee thereof) of Executive’s performance and the Company’s attainment of
targeted goals (as established by the Board or a committee thereof in its sole discretion) over the applicable calendar year.  The
Annual Bonus, if any, will be subject to applicable payroll deductions and withholdings.  No amount of any Annual Bonus is guaranteed
at any time, and, except as otherwise stated in Sections 6.2(a)(iii) or 6.3(a)(iii), Executive must be an employee in good standing through
the date the Annual Bonus is paid to be eligible to receive an Annual Bonus and no partial or prorated bonuses will be provided.
 Unless otherwise stated in Section 6, any Annual Bonus, if awarded, will be paid at the same time annual bonuses are generally paid
to other similarly-situated employees of the Company.  Executive’s eligibility for an Annual Bonus is subject to change in
the discretion of the Board (or any authorized committee thereof).

 

(b) Upon
Termination. Except as otherwise stated in Section 6, in the event Executive leaves the employ of the Company for any reason prior
to the date the Annual Bonus is paid, Executive is not eligible to earn such Annual Bonus, prorated or otherwise.

 

2.3 Company
Equity Awards. Subject to approval of the Board, upon the closing of the Transactions, Executive will be granted an option to
purchase 100,000 shares of the Company’s common stock (the “Option”), pursuant and subject to the Company’s
2020 Equity Incentive Plan (the “Plan”) and other documents issued in connection with the grant (the “Option
Documents”), at an exercise price per share not less than the fair market value of the underlying common stock as of the
date of grant as determined by the Board in accordance with the terms of the Plan. This Option has both a performance vesting schedule
and a service vesting schedule. The Option will vest according to the following schedule:

 

(a) 50%
of the shares subject to the Option will vest based on Executive’s Continuous Service (as defined in the Plan) over a four year
period. Subject to Executive’s Continuous Service on each vesting date, this Option will vest as to 25% of the total number of shares
subject to the Option one year after the Effective Date and as to l/48th of the total number of shares subject to the Option each month
thereafter. Any fractional share will be rounded down to the nearest whole share; and

 

(b) 50%
of the shares subject to the Option will vest based on achievement of performance milestones to be established by the Compensation Committee
of the Board during the first quarter of 2021 and communicated to Executive in writing, subject to Executive’s Continuous Service
through the date such milestones are determined to have been achieved.

 

The specific terms and conditions
of the Option will be as set forth in the Plan and Option Documents and other applicable documents, which Executive may be required to
sign, and the Option shall be subject to all of the terms and conditions of the Plan and the relevant Option Documents.

 

    3

    

    

 

2.4 Business
Development Incentive Compensation: Executive shall be eligible to receive two (2) Business Development Incentive Compensation
bonuses (each a “BDIC”) of up to $100,000 each, less applicable withholding taxes, based on Executive’s contributions
to the Company’s business development efforts, payable as advances on September 23, 2021 and September 23, 2022 and earned through
continued employment, as described below. The Company’s decision to advance these BDICs, if any, and the amount of each BDIC will
be based upon the Executive’s submission of a detailed statement enumerating the business development goals that he had supported
during the preceding year, which will be subject to the company’s reasonable acceptance, upon which the BDICs would be payable and
the amount of the BDICs would be determined. No amount of any BDIC is guaranteed at any time. Executive must be an employee on the dates
the BDIC becomes payable or prorated amounts will be provided.

 

(a) The
first BDIC, if any, will be advanced to Executive on September 23, 2021, subject to Executive’s continued employment through such
payment date, and will be deemed earned if Executive remains in continuous employment through September 23, 2022. The second BDIC will
be advanced to Executive on September 23, 2022, subject to Executive’s continued employment through such payment date, and will
be deemed earned if Executive remains in continuous employment through September 23, 2023.

 

(b) If,
before a BDIC is deemed earned, Executive’s service to the Company terminates for any reason other than Termination by Virtue of
Death or Disability of Executive in accordance with paragraph 6.1 or Executive is terminated without Cause or resigns for Good Reason
in accordance with paragraphs 6.2 or 6.3 of this agreement, Executive will be required to, and hereby agrees to, repay the applicable
BDIC (on a net of tax basis) (such amount, the “Repayment Amount”), provided that the Repayment Amount to be paid by Executive
will be calculated as follows: for each full month of Executive’s employment with the Company following the payment of the applicable
BDIC, the Company will forgive one-twelfth (1/12th) of the Repayment Amount, and the remaining unforgiven portion of the Repayment Amount
will be due and payable by Executive to the Company on demand. Executive agrees that the Company may deduct, in accordance with applicable
law, the Repayment Amount from any payments the Company owes Executive, including but not limited to any regular payroll amount and any
expense payments. Executive further agrees to pay to the Company, within thirty (30) days of the termination date, any remaining unpaid
balance of the Repayment Amount not covered by such deductions.

 

2.5 Expense
Reimbursement. The Company will reimburse Executive for reasonable business expenses in accordance with the Company’s standard
expense reimbursement policy, subject to any applicable payroll withholdings and deductions (if any). For the avoidance of doubt, to the
extent that any reimbursements payable to Executive are subject to the provisions of Section 409A of the Internal Revenue Code of 1986,
as amended (the “Code”): (a) any such reimbursements will be paid no later than December 31 of the year following
the year in which the expense was incurred, (b) the amount of expenses reimbursed in one year will not affect the amount eligible for
reimbursement in any subsequent year, and (c) the right to reimbursement under this Agreement will not be subject to liquidation or exchange
for another benefit.

 

3. Confidential
Information, Inventions, Non-Solicitation and Non-Competition Obligations. In connection with Executive’s continued
employment with the Company, Executive will continue to receive and continue to have access to the Company’s confidential information
and trade secrets. Accordingly, and in consideration of the benefits that Executive is eligible to receive under this Agreement, Executive
agrees to sign the Company’s Employee Confidential Information, Inventions, Non-Solicitation and Non-Competition Agreement (the
“Confidential Information Agreement”), attached as Exhibit A, which contains certain confidentiality,
non-disclosure, non-solicitation and non-competition obligations, among other obligations. The Confidential Information Agreement contains
provisions that are intended by the parties to survive and do survive termination or expiration of this Agreement and will supersede,
prospectively only, any agreement that Executive previously signed relating to the same subject matter.

 

    4

    

    

 

4. Outside
Activities. Except with the prior written consent of the Board, Executive will not, while employed by the Company, undertake
or engage in any other employment, occupation, or business enterprise except for (i) reasonable time devoted to volunteer services for
or on behalf of such religious, educational, non-profit, and/or other charitable organization as Executive may wish to serve, (ii) reasonable
time devoted to activities in the non-profit and business communities consistent with Executive’s position with the Company, and
(iii) such other activities as may be specifically approved by the Chief Executive Officer, in the cases of (i)-(iii), so long as such
activities do not interfere or conflict with the performance of Executive’s duties and responsibilities under this Agreement. This
restriction shall not, however, preclude Executive from (x) owning less than one percent (1%) of the total outstanding shares of
a publicly-traded company, (y) managing Executive’s passive personal investments, or (z) employment or service in any capacity with
Affiliates of the Company. As used in this Agreement, “Affiliates” means, at the time of determination, any
“parent” or “subsidiary” of the Company as such terms are defined in Rule 405 of the Securities Act of 1933, as
amended. The Board will have the authority to determine the time or times at which “parent” or “subsidiary” status
is determined within the foregoing definition.

 

5. No
Conflict with Existing Obligations. Executive represents that Executive’s performance of all the terms of this Agreement
and continued service as an employee of the Company do not and will not breach any agreement or obligation of any kind made prior to Executive’s
employment by the Company, including agreements or obligations Executive may have with prior employers or entities for which Executive
has provided services. Executive has not entered into, and Executive agrees that Executive will not enter into, any agreement or obligation,
either written or oral, in conflict herewith or with Executive’s duties to the Company.

 

6. Termination
Of Employment. The parties acknowledge that Executive’s employment relationship with the Company continues to be
at-will. Either Executive or the Company may terminate the employment relationship at any time, with or without Cause (as defined below)
or advance notice. The provisions in this Section govern the amount of compensation, if any, to be provided to Executive upon termination
of employment and do not alter this at-will status.

 

6.1 Termination
by Virtue of Death or Disability of Executive.

 

(a) In
the event of Executive’s death while employed pursuant to this Agreement, all obligations of the parties hereunder and Executive’s
employment shall terminate immediately, and the Company shall, pursuant to the Company’s standard payroll policies and applicable
law, pay to Executive’s legal representatives the Accrued Obligations (as defined in Section 6.2(c) below) due to Executive.

 

    5

    

    

 

(b) Subject
to applicable state and federal law, the Company shall at all times have the right, upon written notice to Executive, to terminate this
Agreement based on Executive’s Disability (as defined below). Termination by the Company of Executive’s employment based on
“Disability” shall mean termination because Executive is unable due to a physical or mental condition to perform
the essential functions of Executive’s position with or without reasonable accommodation for six (6) months in the aggregate during
any twelve (12) month period or based on the written certification by two licensed physicians of the likely continuation of such condition
for such period. This definition shall be interpreted and applied consistent with the Americans with Disabilities Act, the Family and
Medical Leave Act, and other applicable law. In the event Executive’s employment is terminated based on Executive’s Disability,
Executive will be entitled to the Accrued Obligations due to Executive.

 

(c) In
the event Executive’s employment is terminated based on Executive’s death or Disability, Executive will not receive the Non-CIC
Severance Benefits (as defined below), the CIC Severance Benefits (as defined below), or any other severance compensation or benefit,
except that (i) the Company will provide the Accrued Obligations (as stated in Sections 6.1(a) and 6.1(b)); and (ii) and provided that
Executive (or Executive’s legal representatives, in the event of Executive’s death) comply with the Separation Agreement requirement
stated in 6.2(a)-(b) below, then the Company will pay Executive (or Executive’s legal representatives, in the event of Executive’s
death) an amount equal to the Target Bonus under Section 2.2 for the calendar year in which Executive’s termination occurs, prorated
for any partial year of employment on the basis of a 365-day year, less applicable withholdings and deductions, and payable in a lump
sum on the later of (x) the date that annual performance bonuses are normally paid to other executives at the Company for that calendar
year or (y) the Release Date (as defined below), but in no event later than March 15 of the year following the year to which the bonus
is attributable.

 

6.2 Termination
by the Company or Resignation by Executive (not in connection with a Change in Control).

 

(a) The
Company shall have the right to terminate Executive’s employment pursuant to this Section 6.2 at any time (subject to any applicable
cure period stated in Section 6.2(e)) with or without Cause or advance notice, by giving notice as described in Section 7.1 of this Agreement.
Likewise, Executive can resign from employment with or without Good Reason, by giving notice as described in Section 7.1 of this Agreement.
Executive hereby agrees to comply with the additional notice requirements set forth in Section 6.2(d) below for any resignation for Good
Reason. If Executive is terminated by the Company (with or without Cause) or resigns from employment with the Company (with or without
Good Reason), then Executive shall be entitled to the Accrued Obligations (as defined below). In addition, if Executive is terminated
without Cause or resigns for Good Reason, in either case, outside of the Change in Control Measurement Period (as defined below), and
provided that such termination constitutes a “separation from service” (as defined under Treasury Regulation Section 1.409A-1(h),
without regard to any alternative definition thereunder, a “Separation from Service”), and further provided
that Executive timely executes and allows to become effective a separation agreement that includes, among other terms, a general release
of claims in favor of the Company and its Affiliates and representatives, in the form presented by the Company (the “Separation
Agreement”), and subject to Section 6.2(b) (the date that the general release of claims in the Separation Agreement becomes
effective and may no longer be revoked by Executive is referred to as the “Release Date”), then Executive shall
be eligible to receive the following severance benefits (collectively the “Non-CIC Severance Benefits”):

 

(i) The
Company will pay Executive severance pay in the form of continuation of Executive’s then-current Base Salary for nine (9) months
(the “Non-CIC Severance”). The Non-CIC Severance will be paid in substantially equal installments on the Company’s
regular payroll schedule following the termination date, subject to standard deductions and withholdings; provided, however that
no portion of the Non-CIC Severance will be paid prior to the Release Date, and any such payments that are otherwise scheduled to be made
prior to the Release Date shall instead accrue and be made on the first regular payroll date following the Release Date;

 

    6

    

    

 

(ii) Provided
Executive or Executive’s covered dependents, as the case may be, timely elects continued coverage under COBRA, or state continuation
coverage (as applicable), under the Company’s group health plans following such termination, the Company will pay the COBRA, or
state continuation coverage, premiums to continue Executive’s (and Executive’s covered dependents, as applicable) health insurance
coverage in effect on the termination date until the earliest of: (1) nine (9) months following the termination date; (2) the date when
Executive becomes eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment;
or (3) the date Executive ceases to be eligible for COBRA or state law continuation coverage for any reason, including plan termination
(such period from the termination date through the earlier of (1)-(3), (the “Non-CIC COBRA Payment Period”)).
Notwithstanding the foregoing, if at any time the Company determines that its payment of COBRA, or state continuation coverage, premiums
on Executive’s behalf would result in a violation of applicable law (including, but not limited to, the 2010 Patient Protection
and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of paying such premiums pursuant
to this Section, the Company shall pay Executive on the last day of each remaining month of the Non-CIC COBRA Payment Period, a fully
taxable cash payment equal to the COBRA or state continuation coverage premium for such month, subject to applicable tax withholding,
for the remainder of the Non-CIC COBRA Payment Period. Nothing in this Agreement shall deprive Executive of Executive’s rights under
COBRA or ERISA for benefits under plans and policies arising under Executive’s employment by the Company;

 

(iii) The
Company will pay Executive an amount equal to the Target Bonus under Section 2.2 for the calendar year in which Executive’s termination
occurs, prorated for any partial year of employment on the basis of a 365-day year, less applicable withholdings and deductions, payable
in a lump sum on the later of (x) the date that annual performance bonuses are normally paid to other executives at the Company for that
calendar year or (y) the Release Date, but in no event later than March 15 of the year following the year to which the bonus is attributable;
and

 

(iv) Notwithstanding
the terms of any equity plan or award agreement to the contrary, the unvested portion of all time-based equity awards outstanding on the
date of Executive’s termination that would have vested over the nine (9) month period following the date of Executive’s termination
had Executive remained continuously employed by the Company during such period will be automatically vested and exercisable as of the
date of Executive’s termination.

 

    7

    

    

 

(b) Executive
shall not receive the Non-CIC Severance Benefits pursuant to Section 6.2(a) or the CIC Severance Benefits pursuant to Section 6.3(a),
as applicable, unless Executive executes the Separation Agreement within the consideration period specified therein, which shall in no
event be more than forty-five (45) days, and until the Separation Agreement becomes effective and can no longer be revoked by Executive
under its terms. Executive’s ability to receive the Non-CIC Severance Benefits pursuant to Section 6.2(a) or the CIC Severance Benefits
pursuant to Section 6.3(a), as applicable, is further conditioned upon Executive: (i) returning all Company property; (ii) complying with
Executive’s post-termination obligations under this Agreement and the Confidential Information Agreement; (iii) complying with
the Separation Agreement, including without limitation any non-disparagement and confidentiality provisions contained therein; and (iv)
resignation from any other positions Executive holds with the Company, effective no later than Executive’s date of termination (or
such other date as requested by the Board).

 

(c) For
purposes of this Agreement, “Accrued Obligations” are (i) Executive’s accrued but unpaid salary through
the date of termination, (ii) any unreimbursed business expenses incurred by Executive payable in accordance with the Company’s
standard expense reimbursement policies, and (iii) benefits owed to Executive under any qualified retirement plan or health and welfare
benefit plan in which Executive was a participant in accordance with applicable law and the provisions of such plan.

 

(d) For
purposes of this Agreement, “Good Reason” means any of the following actions taken by the Company without Executive’s
express prior written consent: (i) a material reduction by the Company of Executive’s Base Salary (other than in a broad based reduction
similarly affecting all other members of the Company’s executive management); (ii) the relocation of Executive’s
principal place of employment from the Company’s Florham Park, New Jersey office, without Executive’s consent, to a place
that increases Executive’s one-way commute by more than thirty-five (35) miles as compared to Executive’s then-current principal
place of employment immediately prior to such relocation; or (iii) a material reduction in Executive’s duties, authority,
or responsibilities for the Company relative to Executive’s duties, authority, or responsibilities in effect immediately prior to
such material reduction, provided, however, that neither the conversion of the Company to a subsidiary, division or unit of an acquiring
entity in connection with a change in control, nor a change in title or Executive’s reporting relationships will be deemed a “material
reduction” in and of itself; provided further, that, any such termination by Executive shall only be deemed for Good Reason pursuant
to this definition if: (1) Executive gives the Company written notice of Executive’s intent to terminate for Good Reason within
thirty (30) days following the first occurrence of the condition(s) that Executive believes constitute(s) Good Reason, which notice shall
describe such condition(s); (2) the Company fails to remedy such condition(s) within thirty (30) days following receipt of the written
notice (the “Cure Period”); (3) the Company has not, prior to receiving such notice from Executive, already
informed Executive that Executive’s employment with the Company is being terminated; and (4) Executive voluntarily terminates
Executive’s employment within thirty (30) days following the end of the Cure Period.

 

    8

    

    

 

(e) For
purposes of this Agreement, “Cause” for termination shall mean that Executive has engaged in any of the following:
(i) a material breach of any covenant or condition under this Agreement, the Confidential Information Agreement, or any other material
agreement between the parties; (ii) any act constituting dishonesty, fraud, immoral or disreputable conduct; (iii) any conduct which
constitutes a felony under applicable law; (iv) material violation of any Company policy (including those pertaining to discrimination
or harassment); (v) refusal to follow or implement a clear, lawful and reasonable directive of Company; (vi) gross negligence or incompetence
in the performance of Executive’s duties after the expiration of ten (10) days without cure after written notice of such failure;
or (vii) breach of fiduciary duty to the Company.

 

(f) The
Non-CIC Severance Benefits provided to Executive pursuant to this Section 6.2 are in lieu of, and not in addition to, any benefits to
which Executive may otherwise be entitled under any Company severance plan, policy, or program. For avoidance of doubt, Executive shall
not be eligible to receive both CIC Severance Benefits and Non-CIC Severance Benefits.

 

(g) Any
damages caused by the termination of Executive’s employment without Cause not in connection with a Change in Control would be difficult
to ascertain; therefore, the Non-CIC Severance Benefits for which Executive is eligible pursuant to Section 6.2(a) above in exchange for
the Separation Agreement is agreed to by the parties as liquidated damages, to serve as full compensation, and not a penalty.

 

(h) If
the Company terminates Executive’s employment for Cause, or Executive resigns from employment with the Company without Good Reason,
regardless of whether or not such termination is in connection with a Change in Control (as defined in the Plan, and which, for purposes
of clarity, will not include the Transactions), then Executive shall be entitled to the Accrued Obligations, but Executive will not be
eligible for the Non-CIC Severance Benefits, the CIC Severance Benefits, or any other severance compensation or benefit.

 

6.3 Termination
by the Company without Cause or Resignation by Executive for Good Reason (in connection with a Change in Control).

 

(a) In
the event that the Company terminates Executive’s employment without Cause or Executive resigns for Good Reason, in either case,
within three (3) months prior to or within twelve (12) months following the effective date of a Change in Control (such period, the “Change
in Control Measurement Period”) then Executive shall be entitled to the Accrued Obligations and, subject to Executive’s
full compliance with Section 6.2(b) above, Executive shall be eligible to receive the following severance benefits (collectively the “CIC
Severance Benefits”):

 

(i) The
Company will pay Executive severance pay in the form of continuation of Executive’s then-current Base Salary for twelve (12) months
(the “CIC Severance”). The CIC Severance will be paid in substantially equal installments on the Company’s
regular payroll schedule following the termination date, subject to standard deductions and withholdings; provided, however that
no portion of the CIC Severance will be paid prior to the Release Date, and any such payments that are otherwise scheduled to be made
prior to the Release Date shall instead accrue and be made on the first regular payroll date following the Release Date;

 

    9

    

    

 

(ii) Provided
Executive or Executive’s covered dependents, as the case may be, timely elects continued coverage under COBRA, or state continuation
coverage (as applicable), under the Company’s group health plans following such termination, the Company will pay the COBRA, or
state continuation coverage, premiums to continue Executive’s (and Executive’s covered dependents, as applicable) health insurance
coverage in effect on the termination date until the earliest of: (1) twelve (12) months following the termination date; (2) the date
when Executive becomes eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment;
or (3) the date Executive ceases to be eligible for COBRA or state law continuation coverage for any reason, including plan termination
(such period from the termination date through the earlier of (1)-(3), (the “CIC COBRA Payment Period”)). Notwithstanding
the foregoing, if at any time the Company determines that its payment of COBRA, or state continuation coverage, premiums on Executive’s
behalf would result in a violation of applicable law (including, but not limited to, the 2010 Patient Protection and Affordable Care Act,
as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of paying such premiums pursuant to this Section, the
Company shall pay Executive on the last day of each remaining month of the CIC COBRA Payment Period, a fully taxable cash payment equal
to the COBRA or state continuation coverage premium for such month, subject to applicable tax withholding, for the remainder of the CIC
COBRA Payment Period. Nothing in this Agreement shall deprive Executive of Executive’s rights under COBRA or ERISA for benefits
under plans and policies arising under Executive’s employment by the Company;

 

(iii) The
Company will make a lump sum cash payment to Executive in an amount equal to one (1) times the Target Bonus for the year in which the
termination occurs, subject to standard payroll deductions and withholdings, which will be paid on the first payroll date after the 60th
day following Executive’s date of termination, provided that Executive has delivered an effective Separation Agreement prior to
such date; and

 

(iv) Effective
as of Executive’s termination date or, if later, the date of such Change in Control, the vesting and exercisability of all outstanding
equity awards held by Executive immediately prior to the termination date (if any) shall be accelerated in full.

 

(b) The
CIC Severance Benefits provided to Executive pursuant to this Section 6.3 are in lieu of, and not in addition to, any benefits to which
Executive may otherwise be entitled under any Company severance plan, policy, or program.

 

(c) Any
damages caused by the termination of Executive’s employment without Cause during the Change in Control Measurement Period would
be difficult to ascertain; therefore, the CIC Severance Benefits for which Executive is eligible pursuant to Section 6.3(a) above in exchange
for the Release are agreed to by the parties as liquidated damages, to serve as full compensation, and not a penalty.

 

6.4 Cooperation
With the Company After Termination of Employment. Following termination of Executive’s employment for any reason, Executive
shall reasonably cooperate with the Company in all matters relating to the winding up of Executive’s pending work including, but
not limited to, any litigation in which the Company is involved, and the orderly transfer of any such pending work to such other executives
as may be designated by the Company.

 

    10

    

    

 

6.5 Effect
of Termination. Executive agrees that should Executive’s employment be terminated for any reason, Executive shall be deemed
to have resigned from any and all positions with the Company, including, but not limited to, all positions with any and all subsidiaries
and Affiliates of the Company.

 

6.6 Application
of Section 409A.

 

(a) It
is intended that all of the compensation payable under this Agreement, to the greatest extent possible, either complies with the requirements
of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the regulations and other
guidance thereunder and any state law of similar effect (collectively, “Section 409A”) or satisfies one or more
of the exemptions from the application of Section 409A, and this Agreement will be construed in a manner consistent with such intention,
incorporating by reference all required definitions and payment terms.

 

(b) No
severance payments will be made under this Agreement unless Executive’s termination of employment constitutes a Separation from
Service. For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulations Section 1.409A-2(b)(2)(iii)),
Executive’s right to receive any installment payments under this Agreement (whether severance payments or otherwise) shall be treated
as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered
a separate and distinct payment.

 

(c) To
the extent that any severance payments are deferred compensation under Section 409A, and are not otherwise exempt from the application
of Section 409A, then, to the extent required to comply with Section 409A, if the period during which Executive may consider and sign
the Separation Agreement spans two calendar years, the severance payments will not begin until the second calendar year. If the Company
determines that the severance benefits provided under this Agreement constitutes “deferred compensation” under Section 409A
and if Executive is a “specified employee” of the Company, as such term is defined in Section 409A(a)(2)(B)(i) of the Code
at the time of Executive’s Separation from Service, then, solely to the extent necessary to avoid the incurrence of the adverse
personal tax consequences under Section 409A, the timing of the severance will be delayed as follows: on the earlier to occur of (a) the
date that is six months and one day after Executive’s Separation from Service, and (b) the date of Executive’s death, the
Company will: (i) pay to Executive a lump sum amount equal to the sum of the severance benefits that Executive would otherwise have
received if the commencement of the payment of the severance benefits had not been delayed pursuant to this Section 6.6(c); and (ii) commence
paying the balance of the severance benefits in accordance with the applicable payment schedule set forth in Sections 6.2 and 6.3. No
interest shall be due on any amounts deferred pursuant to this Section 6.6(c).

 

(d) To
the extent required to avoid accelerated taxation and/or tax penalties under Section 409A, amounts reimbursable to Executive under this
Agreement shall be paid to Executive on or before the last day of the year following the year in which the expense was incurred and the
amount of expenses eligible for reimbursement (and in-kind benefits provided to Executive) during any one year may not effect amounts
reimbursable or provided in any subsequent year. The Company makes no representation that compensation paid pursuant to the terms of this
Agreement will be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any
such payment.

 

    11

    

    

 

6.7 Excise
Tax Adjustment.

 

(a) If
any payment or benefit Executive will or may receive from the Company or otherwise (a “280G Payment”) would
(i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this Section,
be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then any such 280G Payment
provided pursuant to this Agreement (a “Payment”) shall be equal to the Reduced Amount. The “Reduced
Amount” shall be either (x) the largest portion of the Payment that would result in no portion of the Payment (after
reduction) being subject to the Excise Tax, or (y) the largest portion, up to and including the total, of the Payment, whichever
amount (i.e., the amount determined by clause (x) or by clause (y)), after taking into account all applicable federal, state, and local
employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive’s
receipt, on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject
to the Excise Tax. If a reduction in a Payment is required pursuant to the preceding sentence and the Reduced Amount is determined pursuant
to clause (x) of the preceding sentence, the reduction shall occur in the manner (the “Reduction Method”) that
results in the greatest economic benefit for Executive. If more than one method of reduction will result in the same economic benefit,
the items so reduced will be reduced pro rata (the “Pro Rata Reduction Method”).

 

(b) Notwithstanding
any provision of this Section 6.7 to the contrary, if the Reduction Method or the Pro Rata Reduction Method would result in any portion
of the Payment being subject to taxes pursuant to Section 409A that would not otherwise be subject to taxes pursuant to Section 409A,
then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, shall be modified so as to avoid the imposition of
taxes pursuant to Section 409A as follows: (A) as a first priority, the modification shall preserve to the greatest extent possible,
the greatest economic benefit for Executive as determined on an after-tax basis; (B) as a second priority, Payments that are contingent
on future events (e.g., being terminated without Cause), shall be reduced (or eliminated) before Payments that are not contingent
on future events; and (C) as a third priority, Payments that are “deferred compensation” within the meaning of Section
409A shall be reduced (or eliminated) before Payments that are not deferred compensation within the meaning of Section 409A.

 

(c) Unless
Executive and the Company agree on an alternative accounting firm or law firm, the accounting firm engaged by the Company for general
tax compliance purposes as of the day prior to the effective date of the Change in Control transaction shall perform the foregoing calculations.
If the accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity, or group effecting the
Change in Control transaction, the Company shall appoint a nationally-recognized accounting or law firm to make the determinations required
by this Section 6.7. The Company shall bear all expenses with respect to the determinations by such accounting or law firm required to
be made hereunder. The Company shall use commercially reasonable efforts to cause the accounting or law firm engaged to make the determinations
hereunder to provide its calculations, together with detailed supporting documentation, to Executive and the Company within fifteen (15)
calendar days after the date on which Executive’s right to a 280G Payment becomes reasonably likely to occur (if requested at that
time by Executive or the Company) or such other time as requested by Executive or the Company.

 

    12

    

    

 

(d) If
Executive receives a Payment for which the Reduced Amount was determined pursuant to clause (x) of Section 6.7(a) and the Internal Revenue
Service determines thereafter that some portion of the Payment is subject to the Excise Tax, Executive agrees to promptly return to the
Company a sufficient amount of the Payment (after reduction pursuant to clause (x) of Section 6.7(a)) so that no portion of the remaining
Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount was determined pursuant to clause (y) of Section
6.7(a), Executive shall have no obligation to return any portion of the Payment pursuant to the preceding sentence.

 

 7. General Provisions.

 

7.1 Notices.
Any notices required hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be
notified, (b) when sent by electronic mail or confirmed facsimile if sent during normal business hours of the recipient, and if not, then
on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage
prepaid, or (d) one (1) day after deposit with a nationally-recognized overnight courier, specifying next-day delivery, with written verification
of receipt. All communications shall be sent to the Company at its primary office location and to Executive at Executive’s address
as listed on the Company payroll or (if notice is given prior to Executive’s termination of employment) to Executive’s Company-issued
email address, or at such other address as the Company or Executive may designate by ten (10) days’ advance written notice to the
other.

 

7.2 Severability.
Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Agreement is held to be invalid, illegal, or unenforceable in any respect under any applicable law or rule
in any jurisdiction, such invalidity, illegality, or unenforceability will not affect any other provision or any other jurisdiction, but
this Agreement will be reformed, construed, and enforced in such jurisdiction as if such invalid, illegal, or unenforceable provisions
had never been contained herein.

 

7.3 Waiver.
If either party should waive any breach of any provisions of this Agreement, Executive or the Company shall not thereby be deemed to have
waived any preceding or succeeding breach of the same or any other provision of this Agreement.

 

7.4 Complete
Agreement. This Agreement (including Exhibit A), and any other separate agreement relating to equity awards constitute the entire
agreement between Executive and the Company with regard to the subject matter hereof and supersede any prior oral discussions or written
communications and agreements, including the Prior Agreement. This Agreement is entered into without reliance on any promise or representation
other than those expressly contained herein, and it cannot be modified or amended except in writing signed by Executive and an authorized
officer of the Company.

 

    13

    

    

 

7.5 Counterparts.
This Agreement may be executed by electronic transmission and in separate counterparts, any one of which need not contain signatures of
more than one party, but all of which taken together will constitute one and the same Agreement.

 

7.6 Headings.
The headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect
the meaning thereof.

 

7.7 Successors
and Assigns. The Company shall assign this Agreement and its rights and obligations hereunder in whole, but not in part, to any
company or other entity with or into which the Company may hereafter merge or consolidate or to which the Company may transfer all or
substantially all of its assets, if in any such case said company or other entity shall by operation of law or expressly in writing assume
all obligations of the Company hereunder as fully as if it had been originally made a party hereto, but may not otherwise assign this
Agreement or its rights and obligations hereunder. Executive may not assign or transfer this Agreement or any rights or obligations hereunder,
other than to Executive’s estate upon Executive’s death.

 

7.8 Choice
of Law. All questions concerning the construction, validity, and interpretation of this Agreement will be governed by the laws
of the State of New Jersey.

 

7.9 Resolution
of Disputes. The parties recognize that litigation in federal or state courts or before federal or state administrative agencies
of disputes arising out of Executive’s employment with the Company or out of this Agreement, or Executive’s termination of
employment or termination of this Agreement, may not be in the best interests of either Executive or the Company, and may result in unnecessary
costs, delays, complexities, and uncertainty. The parties agree that any dispute between the parties arising out of or relating to the
negotiation, execution, performance or termination of this Agreement or Executive’s employment, including, but not limited to, any
claim arising out of this Agreement, claims under Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991,
the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, Section 1981 of the Civil Rights Act of
1966, as amended, the Family Medical Leave Act, the Executive Retirement Income Security Act, and any similar federal, state or local
law, statute, regulation, or any common law doctrine, whether that dispute arises during or after employment, shall be settled by binding
arbitration in accordance with the Employment Arbitration Rules and Mediation Procedures of the American Arbitration Association; provided
however, that this dispute resolution provision shall not apply to any separate agreements between the parties that do not themselves
specify arbitration as an exclusive remedy and further shall not apply to discrimination, harassment, or retaliation claims to the extent
prohibited by applicable law. The location for the arbitration shall be the Northern New Jersey area. Any award made by such panel shall
be final, binding and conclusive on the parties for all purposes, and judgment upon the award rendered by the arbitrators may be entered
in any court having jurisdiction thereof. To the extent applicable law prohibits mandatory arbitration of discrimination, harassment,
and/or retaliation claims, in the event Executive intends to bring multiple claims, including a discrimination, harassment, and/or retaliation
claim, the discrimination, harassment, and/or retaliation claim may be publicly filed with a court, while any other claims will remain
subject to mandatory arbitration. The arbitrators’ fees and expenses and all administrative fees and expenses associated with the
filing of the arbitration shall be borne by the Company; provided however, that at Executive’s option, Executive may voluntarily
pay up to one-half the costs and fees. The parties acknowledge and agree that their obligations to arbitrate under this Section survive
the termination of this Agreement and continue after the termination of the employment relationship between Executive and the Company.
The parties each further agree that the arbitration provisions of this Agreement shall provide each party with its exclusive remedy,
and each party expressly waives any right it might have to seek redress in any other forum, except as otherwise expressly provided in
this Agreement. By election arbitration as the means for final settlement of all claims, the parties hereby waive their respective
rights to, and agree not to, sue each other in any action in a federal, state or local court with respect to such claims, but may seek
to enforce in court an arbitration award rendered pursuant to this Agreement. The parties specifically agree to waive their respective
rights to a trial by jury, and further agree that no demand, request or motion will be made for trial by jury.

 

    14

    

    

 

In
Witness Whereof, the parties have executed this Second Amended and Restated Employment Agreement on the day and year first
written above.

 

	 	Celularity,
    Inc.
	 	 
	 	By:	/s/ John Haines
	 	 	Name: John Haines
	 	 	Title:   Chief Operating Officer
	 	 
	 	EXECUTIVE:
	 	 
	 	/s/
Keary Dunn
	 	Keary Dunn

 

    15

    

    

 

Exhibit A

 

Employee
Confidential Information, Inventions, Non-Solicitation and Non-Competition Agreement

 

 

 

 

A-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]